Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort.
Jingmei Li,
Wei Xiong Wen,
Martin Eklund,
Anders Kvist,
Mikael Eriksson,
Helene Nordahl Christensen,
Astrid Torstensson,
Svetlana Bajalica-Lagercrantz,
Alison M Dunning,
Brennan Decker,
Jamie Allen,
Craig Luccarini,
Karen Pooley,
Jacques Simard,
Leila Dorling,
Douglas F Easton,
Soo-Hwang Teo,
Per Hall,
Åke Borg,
Henrik Grönberg,
Kamila Czene
Oct 03, 2018
Breast cancer patients with BRCA1/2-driven tumors may benefit from targeted therapy. It is not clear whether current BRCA screening guidelines are effective at identifying these patients. The purpose of our study was to evaluate...